Overview of mouse models of inflammatory bowel disease and their use in drug discovery

Current Protocols in Pharmacology

Volumn , Issue SUPPL.47, 2009, Pages

  Maxwell, Joseph R ^a   Viney, Joanne L ^b  

^a AMGEN INC   (United States)

^b AMGEN INC   (United States)

Author keywords

Colitis; IBD; Model; Mouse

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; ADALIMUMAB; AZATHIOPRINE; CERTOLIZUMAB PEGOL; CHEMOKINE RECEPTOR CCR9; CYCLOSPORIN A; DEXAMETHASONE; DEXTRAN SULFATE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; NATALIZUMAB; NERVE CELL ADHESION MOLECULE; OXAZOLONE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STAT4 PROTEIN; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADOPTIVE TRANSFER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC INFLAMMATION; COLITIS; CROHN DISEASE; CYTOKINE PRODUCTION; DIARRHEA; DISEASE MODEL; DRUG RESPONSE; ENTERITIS; EPITHELIUM HYPERPLASIA; HELICOBACTER HEPATICUS; ILEITIS; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE CRYPT; INTESTINE EPITHELIUM; LYMPHOCYTIC INFILTRATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM PROLAPSE; REGULATORY T LYMPHOCYTE; REVIEW; ULCERATIVE COLITIS;

ADOPTIVE TRANSFER; ANIMALS; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; IMMUNITY, INNATE; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 75949091167     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph0557s47     Document Type: Review

References (102)

1. Apostolaki, M., Manoloukos, M., Roulis, M., Wurbel, M.A., Muller, W., Papadakis, K.A., Kontoyiannis, D.L., Malissen, B., and, Kollias, G., 2008. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohns disease. Gastroenterology 134: 2025 - 2035.
2. Atreya, R., Mudter, J., Finotto, S., Mullberg, J., Jostock, T., Wirtz, S., Schutz, M., Bartsch, B., Holtmann, M., Becker, C., Strand, D., Czaja, J., Schlaak, J.F., Lehr, H.A., Autschbach, F., Schrmann, G., Nishimoto, N., Yoshizaki, K., Ito, H., Kishimoto, T., Galle, P.R., Rose-John, S., and, Neurath, M.F., 2000. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6: 583 - 588.
3. Axelsson, L.G., Landstrom, E., and, Bylund-Fellenius, A.C., 1998. Experimental colitis induced by dextran sulphate sodium in mice: Beneficial effects of sulphasalazine and olsalazine. Aliment. Pharmacol. Ther. 12: 925 - 934.
4. Bamias, G., Martin, C., Mishina, M., Ross, W.G., Rivera-Nieves, J., Marini, M., and, Cominelli, F., 2005. Proinflammatory effects of T H 2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology 128: 654 - 666.
5. Bamias, G., Okazawa, A., Rivera-Nieves, J., Arseneau, K.O., De La Rue, S.A., Pizarro, T.T., and, Cominelli, F., 2007. Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis. J. Immunol. 178: 1809 - 1818.
6. Berg, D.J., Davidson, N., Kuhn, R., Muller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M.W., and, Rennick, D., 1996. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4() T H 1-like responses. J. Clin. Invest. 98: 1010 - 1020.
7. Boirivant, M., Fuss, I.J., Chu, A., and, Strober, W., 1998. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 188: 1929 - 1939.
8. Brandwein, S.L., McCabe, R.P., Cong, Y., Waites, K.B., Ridwan, B.U., Dean, P.A., Ohkusa, T., Birkenmeier, E.H., Sundberg, J.P., and, Elson, C.O., 1997. Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J. Immunol. 159: 44 - 52.
9. Burns, R.C., Rivera-Nieves, J., Moskaluk, C.A., Matsumoto, S., Cominelli, F., and, Ley, K., 2001. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohns disease in mice. Gastroenterology 121: 1428 - 1436.
10. Cahill, R.J., Foltz, C.J., Fox, J.G., Dangler, C.A., Powrie, F., and, Schauer, D.B., 1997. Inflammatory bowel disease: An immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect. Immun. 65: 3126 - 3131.
11. Cong, Y., Brandwein, S.L., McCabe, R.P., Lazenby, A., Birkenmeier, E.H., Sundberg, J.P., and, Elson, C.O., 1998. CD4 T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease. J. Exp. Med. 187: 855 - 864.
12. Contractor, N.V., Bassiri, H., Reya, T., Park, A.Y., Baumgart, D.C., Wasik, M.A., Emerson, S.G., and, Carding, S.R., 1998. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J. Immunol. 160: 385 - 394.
13. Cooper, H.S., Murthy, S.N., Shah, R.S., and, Sedergran, D.J., 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69: 238 - 249.
14. Daniel, C., Sartory, N.A., Zahn, N., Radeke, H.H., and, Stein, J.M., 2008. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 324: 23 - 33.
15. Dave, S.H., Tilstra, J.S., Matsuoka, K., Li, F., Karrasch, T., Uno, J.K., Sepulveda, A.R., Jobin, C., Baldwin, A.S., Robbins, P.D., and, Plevy, S.E., 2007. Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide. J. Immunol. 179: 7852 - 7859.
16. Davidson, N.J., Hudak, S.A., Lesley, R.E., Menon, S., Leach, M.W., and, Rennick, D.M., 1998. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Immunol. 161: 3143 - 3149.
17. Dieleman, L.A., Ridwan, B.U., Tennyson, G.S., Beagley, K.W., Bucy, R.P., and, Elson, C.O., 1994. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107: 1643 - 1652.
18. Duchmann, R., Schmitt, E., Knolle, P., Meyer zum Buschenfelde, K.H., and, Neurath, M., 1996. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 26: 934 - 938.
19. Elson, C.O., Beagley, K.W., Sharmanov, A.T., Fujihashi, K., Kiyono, H., Tennyson, G.S., Cong, Y., Black, C.A., Ridwan, B.W., and, McGhee, J.R., 1996. Hapten-induced model of murine inflammatory bowel disease: Mucosa immune responses and protection by tolerance. J. Immunol. 157: 2174 - 2185.
20. Elson, C.O., Cong, Y., Weaver, C.T., Schoeb, T.R., McClanahan, T.K., Fick, R.B., and, Kastelein, R.A., 2007. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132: 2359 - 2370.
21. Fichtner-Feigl, S., Fuss, I.J., Young, C.A., Watanabe, T., Geissler, E.K., Schlitt, H.J., Kitani, A., and, Strober, W., 2007. Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J. Immunol. 178: 5859 - 5870.
22. Fiorucci, S., Mencarelli, A., Palazzetti, B., Sprague, A.G., Distrutti, E., Morelli, A., Novobrantseva, T.I., Cirino, G., Koteliansky, V.E., and, de Fougerolles, A.R., 2002. Importance of innate immunity and collagen binding integrin alpha1beta1 in TNBS-induced colitis. Immunity 17: 769 - 780.
23. Fiorucci, S., Wallace, J.L., Mencarelli, A., Distrutti, E., Rizzo, G., Farneti, S., Morelli, A., Tseng, J.L., Suramanyam, B., Guilford, W.J., and, Parkinson, J.F., 2004. A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc. Natl. Acad. Sci. U.S.A. 101: 15736 - 15741.
24. Fiorucci, S., Orlandi, S., Mencarelli, A., Caliendo, G., Santagada, V., Distrutti, E., Santucci, L., Cirino, G., and, Wallace, J.L., 2007. Enhanced activity of a hydrogen sulphidereleasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br. J. Pharmacol. 150: 996 - 1002.
25. Garrett, W.S., Lord, G.M., Punit, S., Lugo-Villarino, G., Mazmanian, S.K., Ito, S., Glickman, J.N., and, Glimcher, L.H., 2007. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131: 33 - 45.
26. Gorelik, L., and, Flavell, R.A., 2000. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171 - 181.
27. Heller, F., Fuss, I.J., Nieuwenhuis, E.E., Blumberg, R.S., and, Strober, W., 2002. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17: 629 - 638.
28. Hermiston, M.L., and, Gordon, J.I., 1995. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270: 1203 - 1207.
29. Hue, S., Ahern, P., Buonocore, S., Kullberg, M.C., Cua, D.J., McKenzie, B.S., Powrie, F., and, Maloy, K.J., 2006. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203: 2473 - 2483.
30. Iijima, H., Takahashi, I., Kishi, D., Kim, J.K., Kawano, S., Hori, M., and, Kiyono, H., 1999. Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice. J. Exp. Med. 190: 607 - 615.
31. Ikenoue, Y., Tagami, T., and, Murata, M., 2005. Development and validation of a novel IL-10 deficient cell transfer model for colitis. Int. Immunopharmacol. 5: 993 - 1006.
32. Ito, R., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Kita, M., Ueda, Y., Iwakura, Y., Kataoka, K., Okanoue, T., and, Mazda, O., 2006. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin. Exp. Immunol. 146: 330 - 338.
33. Kang, S.S., Bloom, S.M., Norian, L.A., Geske, M.J., Flavell, R.A., Stappenbeck, T.S., and, Allen, P.M., 2008. An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med. 5: e41.
34. Kato, S., Hokari, R., Matsuzaki, K., Iwai, A., Kawaguchi, A., Nagao, S., Miyahara, T., Itoh, K., Ishii, H., and, Miura, S., 2000. Amelioration of murine experimental colitis by inhibition of mucosal addressin cell adhesion molecule-1. J. Pharmacol. Exp. Ther. 295: 183 - 189.
35. Kawaguchi-Miyashita, M., Shimada, S., Kurosu, H., Kato-Nagaoka, N., Matsuoka, Y., Ohwaki, M., Ishikawa, H., and, Nanno, M., 2001. An accessory role of TCRgammadelta () cells in the exacerbation of inflammatory bowel disease in TCRalpha mutant mice. Eur. J. Immunol. 31: 980 - 988.
36. Kobayashi, M., Kweon, M.N., Kuwata, H., Schreiber, R.D., Kiyono, H., Takeda, K., and, Akira, S., 2003. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J. Clin. Invest. 111: 1297 - 1308.
37. Kojima, R., Kuroda, S., Ohkishi, T., Nakamaru, K., and, Hatakeyama, S., 2004. Oxazolone-induced colitis in BALB/C mice: A new method to evaluate the efficacy of therapeutic agents for ulcerative colitis. J. Pharmacol. Sci. 96: 307 - 313.
38. Kojouharoff, G., Hans, W., Obermeier, F., Mannel, D.N., Andus, T., Scholmerich, J., Gross, V., and, Falk, W., 1997. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin. Exp. Immunol. 107: 353 - 358.
39. Kontoyiannis, D., Pasparakis, M., Pizarro, T.T., Cominelli, F., and, Kollias, G., 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies. Immunity 10: 387 - 398.
40. Kontoyiannis, D., Boulougouris, G., Manoloukos, M., Armaka, M., Apostolaki, M., Pizarro, T., Kotlyarov, A., Forster, I., Flavell, R., Gaestel, M., Tsichlis, P., Cominelli, F., and, Kollias, G., 2002. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohns-like inflammatory bowel disease. J. Exp. Med. 196: 1563 - 1574.
41. Kosiewicz, M.M., Nast, C.C., Krishnan, A., Rivera-Nieves, J., Moskaluk, C.A., Matsumoto, S., Kozaiwa, K., and, Cominelli, F., 2001. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohns disease. J. Clin. Invest. 107: 695 - 702.
42. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and, Muller, W., 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263 - 274.
43. Kullberg, M.C., Rothfuchs, A.G., Jankovic, D., Caspar, P., Wynn, T.A., Gorelick, P.L., Cheever, A.W., and, Sher, A., 2001. Helicobacter hepaticusinduced colitis in interleukin-10-deficient mice: Cytokine requirements for the induction and maintenance of intestinal inflammation. Infect. Immun. 69: 4232 - 4241.
44. Li, X., Fox, J.G., Whary, M.T., Yan, L., Shames, B., and, Zhao, Z., 1998. SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis. Infect. Immun. 66: 5477 - 5484.
45. Maggio-Price, L., Shows, D., Waggie, K., Burich, A., Zeng, W., Escobar, S., Morrissey, P., and, Viney, J.L., 2002. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a -/-) mice. Am. J. Pathol. 160: 739 - 751.
46. Mahler, M., Bristol, I.J., Leiter, E.H., Workman, A.E., Birkenmeier, E.H., Elson, C.O., and, Sundberg, J.P., 1998. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am. J. Physiol. 274: G544 - 551.
47. Mahler, M., and, Leiter, E.H., 2002. Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice. Inflamm. Bowel Dis. 8: 347 - 355.
48. Mannon, P.J., Fuss, I.J., Mayer, L., Elson, C.O., Sandborn, W.J., Present, D., Dolin, B., Goodman, N., Groden, C., Hornung, R.L., Quezado, M., Neurath, M.F., Salfeld, J., Veldman, G.M., Schwertschlag, U., and, Strober, W., 2004. Anti-interleukin-12 antibody for active Crohns disease. N. Engl. J. Med. 351: 2069 - 2079.
49. Marini, M., Bamias, G., Rivera-Nieves, J., Moskaluk, C.A., Hoang, S.B., Ross, W.G., Pizarro, T.T., and, Cominelli, F., 2003. TNF-alpha neutralization ameliorates the severity of murine Crohns-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc. Natl. Acad. Sci. U.S.A. 100: 8366 - 8371.
50. Matsumoto, S., Okabe, Y., Setoyama, H., Takayama, K., Ohtsuka, J., Funahashi, H., Imaoka, A., Okada, Y., and, Umesaki, Y., 1998. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 43: 71 - 78.
51. Mitsuyama, K., Matsumoto, S., Rose-John, S., Suzuki, A., Hara, T., Tomiyasu, N., Handa, K., Tsuruta, O., Funabashi, H., Scheller, J., Toyonaga, A., and, Sata, M., 2006. STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice. Gut 55: 1263 - 1269.
52. Mizoguchi, A., Mizoguchi, E., Smith, R.N., Preffer, F.I., and, Bhan, A.K., 1997. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J. Exp. Med. 186: 1749 - 1756.
53. Mizoguchi, A., Mizoguchi, E., and, Bhan, A.K., 1999. The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor alpha mutant mice. Gastroenterology 116: 320 - 326.
54. Mombaerts, P., Mizoguchi, E., Grusby, M.J., Glimcher, L.H., Bhan, A.K., and, Tonegawa, S., 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75: 274 - 282.
55. Murano, M., Maemura, K., Hirata, I., Toshina, K., Nishikawa, T., Hamamoto, N., Sasaki, S., Saitoh, O., and, Katsu, K., 2000. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin. Exp. Immunol. 120: 51 - 58.
56. Murthy, S.N., Cooper, H.S., Shim, H., Shah, R.S., Ibrahim, S.A., and, Sedergran, D.J., 1993. Treatment of dextran sulfate sodiuminduced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38: 1722 - 1734.
57. Myers, K.J., Murthy, S., Flanigan, A., Witchell, D.R., Butler, M., Murray, S., Siwkowski, A., Goodfellow, D., Madsen, K., and, Baker, B., 2003. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis. J. Pharmacol. Exp. Ther. 304: 411 - 424.
58. Naito, Y., Takagi, T., Uchiyama, K., Kuroda, M., Kokura, S., Ichikawa, H., Yanagisawa, R., Inoue, K., Takano, H., Satoh, M., Yoshida, N., Okanoue, T., and, Yoshikawa, T., 2004. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int. J. Mol. Med. 14: 191 - 196.
59. Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., Gumucio, D., Neurath, M.F., and, Pasparakis, M., 2007. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446: 557 - 561.
60. Neurath, M.F., Fuss, I., Kelsall, B.L., Stuber, E., and, Strober, W., 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182: 1281 - 1290.
61. Neurath, M.F., Pettersson, S., Meyer zum Buschenfelde, K.H., and, Strober, W., 1996. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 2: 998 - 1004.
62. Neurath, M.F., Fuss, I., Pasparakis, M., Alexopoulou, L., Haralambous, S., Meyer zum Buschenfelde, K.H., Strober, W., and, Kollias, G., 1997. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur. J. Immunol. 27: 1743 - 1750.
63. Obermeier, F., Kojouharoff, G., Hans, W., Scholmerich, J., Gross, V., and, Falk, W., 1999. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin. Exp. Immunol. 116: 238 - 245.
64. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., and, Nakaya, R., 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694 - 702.
65. Panwala, C.M., Jones, J.C., and, Viney, J.L., 1998. A novel model of inflammatory bowel disease: Mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J. Immunol. 161: 5733 - 5744.
66. Picarella, D., Hurlbut, P., Rottman, J., Shi, X., Butcher, E., and, Ringler, D.J., 1997. Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4 T cells. J. Immunol. 158: 2099 - 2106.
67. Powrie, F., Leach, M.W., Mauze, S., Caddle, L.B., and, Coffman, R.L., 1993. Phenotypically distinct subsets of CD4 T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5: 1461 - 1471.
68. Powrie, F., Leach, M.W., Mauze, S., Menon, S., Caddle, L.B., and, Coffman, R.L., 1994. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4 T cells. Immunity 1: 553 - 562.
69. Rakoff-Nahoum, S., Hao, L., and, Medzhitov, R., 2006. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25: 319 - 329.
70. Read, S., and, Powrie, F., 1999. Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells. Curr. Protoc. Immunol. 30: 15.13.1 - 15.13.10.
71. Rijcken, E.M., Laukoetter, M.G., Anthoni, C., Meier, S., Mennigen, R., Spiegel, H.U., Bruewer, M., Senninger, N., Vestweber, D., and, Krieglstein, C.F., 2004. Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G115 - G124.
72. Rivera-Nieves, J., Bamias, G., Vidrich, A., Marini, M., Pizarro, T.T., McDuffie, M.J., Moskaluk, C.A., Cohn, S.M., and, Cominelli, F., 2003. Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis. Gastroenterology 124: 972 - 982. (Pubitemid 36389800)
73. Rivera-Nieves, J., Olson, T., Bamias, G., Bruce, A., Solga, M., Knight, R.F., Hoang, S., Cominelli, F., and, Ley, K., 2005. L-selectin, alpha 4 beta 1, and alpha 4 beta 7 integrins participate in CD4 T cell recruitment to chronically inflamed small intestine. J. Immunol. 174: 2343 - 2352.
74. Rivera-Nieves, J., Ho, J., Bamias, G., Ivashkina, N., Ley, K., Oppermann, M., and, Cominelli, F., 2006. Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis. Gastroenterology 131: 1518 - 1529.
75. Rudolph, U., Finegold, M.J., Rich, S.S., Harriman, G.R., Srinivasan, Y., Brabet, P., Boulay, G., Bradley, A., and, Birnbaumer, L., 1995. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat. Genet. 10: 143 - 150.
76. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A.C., and, Horak, I., 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253 - 261.
77. Sadlack, B., Lohler, J., Schorle, H., Klebb, G., Haber, H., Sickel, E., Noelle, R.J., and, Horak, I., 1995. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4 T cells. Eur. J. Immunol. 25: 3053 - 3059.
78. Schreiber, S., Fedorak, R.N., Nielsen, O.H., Wild, G., Williams, C.N., Nikolaus, S., Jacyna, M., Lashner, B.A., Gangl, A., Rutgeerts, P., Isaacs, K., Van Deventer, S.J.H., Koningsberger, J.C., Cohard, M., LeBeaut, A., and, Hanauer, S.B., 2000. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohns disease. Gastroenterology 119: 1461 - 1472. (Pubitemid 32198671)
79. Schultz, M., Tonkonogy, S.L., Sellon, R.K., Veltkamp, C., Godfrey, V.L., Kwon, J., Grenther, W.B., Balish, E., Horak, I., and, Sartor, R.B., 1999. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am. J. Physiol. 276: G1461 - 1472.
80. Shibata, W., Maeda, S., Hikiba, Y., Yanai, A., Ohmae, T., Sakamoto, K., Nakagawa, H., Ogura, K., and, Omata, M., 2007. Cutting edge: The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis. J. Immunol. 179: 2681 - 2685.
81. Shomer, N.H., Dangler, C.A., Schrenzel, M.D., and, Fox, J.G., 1997. Helicobacter bilisinduced inflammatory bowel disease in scid mice with defined flora. Infect. Immun. 65: 4858 - 4864.
82. Singh, B., Read, S., Asseman, C., Malmstrom, V., Mottet, C., Stephens, L.A., Stepankova, R., Tlaskalova, H., and, Powrie, F., 2001. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182: 190 - 200. (Pubitemid 33070218)
83. Specht, S., Arriens, S., and, Hoerauf, A., 2006. Induction of chronic colitis in IL-10 deficient mice requires IL-4. Microbes Infect. 8: 694 - 703.
84. Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., and, Remaut, E., 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352 - 1355.
85. Stevceva, L., Pavli, P., Husband, A., Ramsay, A., and, Doe, W.F., 2001. Dextran sulphate sodium-induced colitis is ameliorated in interleukin 4 deficient mice. Genes Immun. 2: 309 - 316.
86. Sundberg, J.P., Elson, C.O., Bedigian, H., and, Birkenmeier, E.H., 1994. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology 107: 1726 - 1735.
87. Takagi, H., Kanai, T., Okazawa, A., Kishi, Y., Sato, T., Takaishi, H., Inoue, N., Ogata, H., Iwao, Y., Hoshino, K., Takeda, K., Akira, S., Watanabe, M., Ishii, H., and, Hibi, T., 2003. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand. J. Gastroenterol. 38: 837 - 844.
88. Takahashi, I., Kiyono, H., and, Hamada, S., 1997. CD4 T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology 112: 1876 - 1886.
89. Takeda, K., Clausen, B.E., Kaisho, T., Tsujimura, T., Terada, N., Forster, I., and, Akira, S., 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10: 39 - 49.
90. te Velde, A.A., Verstege, M.I., and, Hommes, D.W., 2006. Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm. Bowel Dis. 12: 995 - 999.
91. Torrence, A.E., Brabb, T., Viney, J.L., Bielefeldt-Ohmann, H., Treuting, P., Seamons, A., Drivdahl, R., Zeng, W., and, Maggio-Price, L., 2008. Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease. Inflamm. Bowel Dis. 14: 480 - 490.
92. Totsuka, T., Kanai, T., Uraushihara, K., Iiyama, R., Yamazaki, M., Akiba, H., Yagita, H., Okumura, K., and, Watanabe, M., 2003. Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G595 - G603.
93. Totsuka, T., Kanai, T., Nemoto, Y., Makita, S., Okamoto, R., Tsuchiya, K., and, Watanabe, M., 2007. IL-7 Is essential for the development and the persistence of chronic colitis. J. Immunol. 178: 4737 - 4748.
94. Uhlig, H.H., McKenzie, B.S., Hue, S., Thompson, C., Joyce-Shaikh, B., Stepankova, R., Robinson, N., Buonocore, S., Tlaskalova-Hogenova, H., Cua, D.J., and, Powrie, F., 2006. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25: 309 - 318.
95. von Freeden-Jeffry, U., Davidson, N., Wiler, R., Fort, M., Burdach, S., and, Murray, R., 1998. IL-7 deficiency prevents development of a non-T cell non-B cell-mediated colitis. J. Immunol. 161: 5673 - 5680.
96. Ward, J.M., Anver, M.R., Haines, D.C., Melhorn, J.M., Gorelick, P., Yan, L., and, Fox, J.G., 1996. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab. Anim. Sci. 46: 15 - 20.
97. Watanabe, M., Ueno, Y., Yajima, T., Okamoto, S., Hayashi, T., Yamazaki, M., Iwao, Y., Ishii, H., Habu, S., Uehira, M., Nishimoto, H., Ishikawa, H., Hata, J., and, Hibi, T., 1998. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J. Exp. Med. 187: 389 - 402.
98. Wilk, J.N., Bilsborough, J., and, Viney, J.L., 2005. The mdr1a -/- mouse model of spontaneous colitis: A relevant and appropriate animal model to study inflammatory bowel disease. Immunol. Res. 31: 151 - 159.
99. Wirtz, S., Finotto, S., Kanzler, S., Lohse, A.W., Blessing, M., Lehr, H.A., Galle, P.R., and, Neurath, M.F., 1999. Cutting edge: Chronic intestinal inflammation in STAT-4 transgenic mice: Characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4 T cells that respond to bacterial antigens. J. Immunol. 162: 1884 - 1888.
100. Wirtz, S., Neufert, C., Weigmann, B., and, Neurath, M.F., 2007. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2: 541 - 546.
101. Yamazaki, M., Yajima, T., Tanabe, M., Fukui, K., Okada, E., Okamoto, R., Oshima, S., Nakamura, T., Kanai, T., Uehira, M., Takeuchi, T., Ishikawa, H., Hibi, T., and, Watanabe, M., 2003. Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis. J. Immunol. 171: 1556 - 1563.
102. Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., McKenzie, B., Kleinschek, M.A., Owyang, A., Mattson, J., Blumenschein, W., Murphy, E., Sathe, M., Cua, D.J., Kastelein, R.A., and, Rennick, D., 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116: 1310 - 1316.